发明名称 Bacteriophage gene 3 protein compositions and use as amyloid binding agents
摘要 The invention relates to agents and to pharmaceutical compositions for reducing the formation of amyloid and/or for promoting the disaggregation of amyloid proteins. The compositions may also be used to detect amyloid.
申请公布号 US9493515(B2) 申请公布日期 2016.11.15
申请号 US201214361157 申请日期 2012.11.28
申请人 PROCLARA BIOSCIENCES, INC. 发明人 Krishnan Rajaraman;Fisher Richard
分类号 A61K51/10;C07K16/00;C07K14/24;C07K14/005;A61K38/16;A61K47/48;B82Y5/00;C12N7/00;A61K38/00 主分类号 A61K51/10
代理机构 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP 代理人 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
主权项 1. A pharmaceutical composition comprising a fusion protein that comprises an amyloid-binding polypeptide and an immunoglobulin IgG constant region, wherein the amyloid binding polypeptide is present in an amount sufficient to treat a disease or disorder associated with misfolded and/or aggregated amyloid protein and a pharmaceutically acceptable carrier, and wherein the polypeptide comprises at least one of: (a) a wild type g3p;(b) an amyloid-binding fragment of wild type g3p; or(c) a mutant of (a) or (b) that retains the ability to bind to amyloid.
地址 Cambridge MA US